Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance Beginning at Dec. 31, 2023	$ 1	$ 248,039	$ (169,600)	$ 78,440
Balance Beginning (in Shares) at Dec. 31, 2023	11,163,896
Issuance of common stock upon exercise of stock options		154		154
Issuance of common stock upon exercise of stock options (in Shares)	21,657
Issuance of common stock through underwritten offering, net of discounts and commissions and issuance costs of $3.3 million	$ 1	47,194		47,195
Issuance of common stock through underwritten offering, net of discounts and commissions and issuance costs of $3.3 million (in Shares)	3,900,000
Stock-based compensation expense		1,169		1,169
Net loss			(13,728)	(13,728)
Balance Ending at Mar. 31, 2024	$ 2	296,556	(183,328)	113,230
Balance Ending (in Shares) at Mar. 31, 2024	15,085,553
Balance Beginning at Dec. 31, 2024	$ 2	302,541	(240,869)	61,674
Balance Beginning (in Shares) at Dec. 31, 2024	15,022,122
Stock-based compensation expense		1,811		1,811
Net loss			(21,241)	(21,241)
Balance Ending at Mar. 31, 2025	$ 2	$ 304,352	$ (262,110)	$ 42,244
Balance Ending (in Shares) at Mar. 31, 2025	15,022,122